Trade IVA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Inventiva S.A. American Depository Shares (IVA) is trading at US$4.71, down 3.98% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$1.11B. Over the past 52 weeks, IVA has traded between US$3.35 and US$7.98. On Syfe you can trade IVA with $0 commission and add it to your watchlist.
| Previous close | US$4.90 |
|---|---|
| Market cap | US$1.11B |
| 52-week range | US$3.35 – US$7.98 |
| Volume | 1.12M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Inventiva S.A. American Depository Shares
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Year: 2020
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight
Jul 17, 11:28 AM · MT Newswires
Inventiva 2025 Loss Narrows, Revenue Falls
Mar 30, 8:49 PM · MT Newswires
-- Earnings Flash (IVA) Inventiva Posts 2025 Per-Share Loss 1.90 Euros
Mar 30, 8:25 PM · MT Newswires
-- Earnings Flash (IVA) Inventiva Posts 2025 Revenue 4.5 Million Euros
Mar 30, 8:23 PM · MT Newswires
Truist Initiates Inventiva at Buy With $13 Price Target
Mar 19, 10:41 AM · MT Newswires
Stay on top of IVA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
